Clinical Trial: Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06393504) titled 'Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)' on April 26.

Brief Summary: Healthcare claims database study to provide safety information on maternal, fetal and infant outcomes among women exposed to QUVIVIQ (daridorexant) during pregnancy

Study Type: Observational

Condition: Insomnia Disorder

Intervention: * Drug: Daridorexant

Daridorexant received during or shortly prior to pregnancy.

Other Name: QUVIVIQ

* Drug: Non-orexin receptor antagonist insomnia medication

Non-orexin receptor antagonist insomnia medication received during or shortly prior to pregnanc...